Literature DB >> 26063340

P2Y2 nucleotide receptor-mediated extracellular signal-regulated kinases and protein kinase C activation induces the invasion of highly metastatic breast cancer cells.

So Young Eun1, Young Shin Ko1, Sang Won Park1, Ki Churl Chang1, Hye Jung Kim1.   

Abstract

Tumor metastasis is considered the main cause of mortality in cancer patients, thus it is important to investigate the differences between high- and low-metastatic cancer cells. Our previous study showed that the highly metastatic breast cancer cell line MDA-MB-231 released higher levels of ATP and exhibited higher P2Y2R activity compared with the low-metastatic breast cancer cell line MCF-7. In addition, P2Y2R activation by ATP released from MDA-MB-231 cells induced hypoxia-inducible factor-1α expression, lysyl oxidase secretion and collagen crosslinking, generating a receptive microenvironment for pre-metastatic niche formation. Thus, in the present study, we investigated which P2Y2R-related signaling pathways are involved in the invasion of breast cancer cells. The highly metastatic breast cancer cells MDA-MB-231 and SK-BR-3 showed higher invasion than MCF-7 and T47D cells at a basal level, which was abolished through P2Y2R knockdown or in the presence of apyrase, an enzyme that hydrolyzes extracellular nucleotides. MDA-MB-231 cells also showed high levels of mesenchymal markers, such as Snail, Vimentin and N-cadherin, but not the epithelial marker E-cadherin and this expression was inhibited through ATP degradation or P2Y2R knockdown. Moreover, SK-BR-3 and MDA-MB231 cells exhibited higher ERK and PKC phosphorylation levels than T47D and MCF-7 cells and upregulated phospho-ERK and -PKC levels in MDA-MB-231 cells were significantly downregulated by apyrase or P2Y2R knockdown. Specific inhibitors of ERK, PKC and PLC markedly reduced the invasion and levels of mesenchymal marker expression in MDA-MB-231 cells. These results suggest that over-activated ERK and PKC pathways are involved in the P2Y2R-mediated invasion of breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26063340     DOI: 10.3892/or.2015.3972

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  17 in total

Review 1.  Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT).

Authors:  A S Martínez-Ramírez; M Díaz-Muñoz; A Butanda-Ochoa; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2016-11-29       Impact factor: 3.765

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

3.  P2Y2 Nucleotide Receptor Prompts Human Cardiac Progenitor Cell Activation by Modulating Hippo Signaling.

Authors:  Farid G Khalafalla; Steven Greene; Hashim Khan; Kelli Ilves; Megan M Monsanto; Roberto Alvarez; Monica Chavarria; Jonathan Nguyen; Benjamin Norman; Walter P Dembitsky; Mark A Sussman
Journal:  Circ Res       Date:  2017-09-18       Impact factor: 17.367

4.  Disruption of ZNF334 promotes triple-negative breast carcinoma malignancy through the SFRP1/ Wnt/β-catenin signaling axis.

Authors:  Zhaobo Cheng; Renjie Yu; Li Li; Junhao Mu; Yijia Gong; Fan Wu; Yujia Liu; Xiangyi Zhou; Xiaohua Zeng; Yongzhong Wu; Ran Sun; Tingxiu Xiang
Journal:  Cell Mol Life Sci       Date:  2022-05-04       Impact factor: 9.261

5.  Is the regulation by miRNAs of NTPDase1 and ecto-5'-nucleotidase genes involved with the different profiles of breast cancer subtypes?

Authors:  Fernanda Cardoso da Silva; Angelo Borges de Melo Neto; Christina Aparecida Martins; Thaís Cunha de Sousa Cardoso; Matheus de Souza Gomes; Thaise Gonçalves de Araújo; Cristina Ribas Fürstenau
Journal:  Purinergic Signal       Date:  2021-11-05       Impact factor: 3.765

Review 6.  Autocrine and paracrine purinergic signaling in the most lethal types of cancer.

Authors:  M Reyna-Jeldes; M Díaz-Muñoz; J A Madariaga; C Coddou; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2021-05-12       Impact factor: 3.765

Review 7.  P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications.

Authors:  Lucas T Woods; Kevin Muñoz Forti; Vinit C Shanbhag; Jean M Camden; Gary A Weisman
Journal:  Biochem Pharmacol       Date:  2021-01-04       Impact factor: 5.858

8.  The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma.

Authors:  Hiroaki Miyahara; Sridevi Yadavilli; Manabu Natsumeda; Jeffrey A Rubens; Louis Rodgers; Madhuri Kambhampati; Isabella C Taylor; Harpreet Kaur; Laura Asnaghi; Charles G Eberhart; Katherine E Warren; Javad Nazarian; Eric H Raabe
Journal:  Cancer Lett       Date:  2017-04-25       Impact factor: 9.756

Review 9.  Important roles of P2Y receptors in the inflammation and cancer of digestive system.

Authors:  Han-Xing Wan; Jian-Hong Hu; Rei Xie; Shi-Ming Yang; Hui Dong
Journal:  Oncotarget       Date:  2016-05-10

Review 10.  Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.

Authors:  Paola de Andrade Mello; Robson Coutinho-Silva; Luiz Eduardo Baggio Savio
Journal:  Front Immunol       Date:  2017-11-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.